Page last updated: 2024-09-05

organophosphonates and Fasting Hypoglycemia

organophosphonates has been researched along with Fasting Hypoglycemia in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Barrish, JC; Behnia, K; Bolton, S; Brigance, RP; Cap, M; Chen, BC; Chen, S; Chen, XQ; Cheng, PTW; Ellsworth, B; Everlof, G; Fuentes-Catanio, HG; Fura, A; Griffen, S; Gupta, A; Janovitz, EB; Jones, B; Kalinowski, S; Kirby, M; Kopcho, L; Krupinski, J; Krystek, SR; Kunselman, L; Langish, RA; Leith, LW; Li, YX; Liu, H; Ma, X; Marcinkeviciene, J; Mathur, A; Meng, W; Muckelbauer, JK; Nielsen, L; O'Malley, K; Pannacciulli, N; Rampulla, R; Robl, JA; Ryono, DE; Shi, Y; Smirk, R; Spronk, SA; Staal, A; Sulsky, R; Sun, D; Sun, JH; Swartz, J; Tao, S; Taylor, JR; Tino, JA; Wang, A; Wang, Q; Wang, Y; Whaley, J; Williams, KN; Wong, MKY; Wu, DR; Xu, C; Yang, Y; Zahler, R; Zalaznick, J; Zebo, R; Zhang, H; Zinker, BA1

Other Studies

1 other study(ies) available for organophosphonates and Fasting Hypoglycemia

ArticleYear
Discovery of a Partial Glucokinase Activator Clinical Candidate: Diethyl ((3-(3-((5-(Azetidine-1-carbonyl)pyrazin-2-yl)oxy)-5-isopropoxybenzamido)-1
    Journal of medicinal chemistry, 2022, 03-10, Volume: 65, Issue:5

    Topics: Azetidines; Diabetes Mellitus, Type 2; Glucokinase; Humans; Hypoglycemia; Hypoglycemic Agents; Organophosphonates

2022